Gustavo C. Penna

Belo Horizonte, MG, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Single 0.9-mg intramuscular rhTSH dose achieves target TSH levels in differentiated thyroid carcinoma.

Single 0.9-mg intramuscular rhTSH dose achieves target TSH levels in differentiated thyroid carcinoma.

Journal: Endocrine
Published: February 23, 2026

Challenges in treating radioiodine-refractory thyroid cancer: a global perspective with a focus on developing nations in Latin America.

Challenges in treating radioiodine-refractory thyroid cancer: a global perspective with a focus on developing nations in Latin America.

Journal: Endocrine
Published: April 30, 2024

Differentiated thyroid carcinoma: what the nonspecialists needs to know.

Differentiated thyroid carcinoma: what the nonspecialists needs to know.

Journal: Archives of endocrinology and metabolism
Published: March 01, 2024

Thyroid Hormone Homeostasis in Levothyroxine-treated Patients: Findings From ELSA-Brasil.

Thyroid Hormone Homeostasis in Levothyroxine-treated Patients: Findings From ELSA-Brasil.

Journal: The Journal of clinical endocrinology and metabolism
Published: November 20, 2023

A Cross-Sectional Analysis of Cardiovascular and Bone Health Care Utilization During Treatment With Thyroid Hormone.

A Cross-Sectional Analysis of Cardiovascular and Bone Health Care Utilization During Treatment With Thyroid Hormone.

Journal: The Journal of clinical endocrinology and metabolism
Published: August 10, 2023

Gene polymorphisms and thyroid hormone signaling: implication for the treatment of hypothyroidism.

Gene polymorphisms and thyroid hormone signaling: implication for the treatment of hypothyroidism.

Journal: Endocrine
Published: May 31, 2023

Congenital hypothyroidism and thyroid cancer.

Congenital hypothyroidism and thyroid cancer.

Journal: Endocrine-related cancer
Published: August 11, 2021

TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma.

TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma.

Journal: Endocrine
Published: March 17, 2018

Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.

Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.

Journal: Cytogenetic and genome research
Published: February 24, 2017

The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic Implications.

The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic Implications.

Journal: Current genomics
Published: August 30, 2016

Predictive factors of malignancy in thyroid nodules with repeatedly nondiagnostic cytology (Bethesda category I): value of ultrasonography.

Predictive factors of malignancy in thyroid nodules with repeatedly nondiagnostic cytology (Bethesda category I): value of ultrasonography.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Published: February 08, 2014

Noninvasive encapsulated follicular variant of papillary thyroid carcinoma: is lobectomy sufficient for tumours ≥1 cm?

Noninvasive encapsulated follicular variant of papillary thyroid carcinoma: is lobectomy sufficient for tumours ≥1 cm?

Journal: Clinical endocrinology
Published: December 20, 2013
Showing 1-12 of 13

Last Updated: 09/26/2026